Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


MM27: Implications and Prevalence of Mutations in SARS-CoV-2

In this presentation, Dr. Roger Paredes reviews the implications and prevalence of mutations in SARS-CoV-2.
Roger Paredes, MD, PhD
Released: December 4, 2020

Information on this Educational Activity


Roger Paredes, MD, PhD

Head, Microbial Genomics  
irsiCaixa AIDS Research Institute
Department of Infectious Diseases
Hospital Universitari Germans Trias i Pujol
Badalona, Catalonia, Spain

Roger Paredes, MD, PhD, has received consulting fees and grant support from Gilead Sciences, Merck Sharp & Dohme, and ViiV Healthcare.

Program Medium

This program has been made available online.

Related Content

Dr Roger Paredes on treating mild cases of COVID-19 with antiviral agents to reduce symptom duration, from Clinical Care Options (CCO)

Roger Paredes, MD, PhD Released: December 5, 2022

La Dra. Cristina Mussini analiza si los antivirales contra la COVID-19 están resultando beneficiosos para la prevención y/o el tratamiento de la COVID persistente, de Clinical Care Options (CCO)

Cristina Mussini, MD Released: December 5, 2022

La dott.ssa Cristina Mussini discute se gli antivirali contro la COVID-19 si stiano dimostrando utili nella prevenzione e/o nel trattamento della Long COVID, da Clinical Care Options (CCO)

Cristina Mussini, MD Released: December 5, 2022

Cristina Mussini, MD Released: December 5, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings